T1	Assertion 41 47	desire
E1	Assertion:T1 Asserted:E40
T2	Eq-Comparison 145 160	score of 3 or 4
E2	Eq-Comparison:T2 Unit:T3 Value:T5 Value2:T4 Operator:T6
T3	Eq-Unit 145 150	score
T4	Eq-Value 154 155	3
T5	Eq-Value 159 160	4
T6	Eq-Operator 156 158	or
A1	Eq-Operator-Value T6 BETWEEN
T7	Observation 168 197	Wrinkle Severity Rating Scale
E3	Observation:T7 Name:T8 Eq-Comparison:E2
T8	Observation-Name 168 197	Wrinkle Severity Rating Scale
A2	Observation-Type-Value T8 clinical-score
T9	Observation 199 203	WSRS
E4	Observation:T9 Name:T10
T10	Observation-Name 199 203	WSRS
R1	Abbrev-Of Arg1:E4 Arg2:E3	
T11	Negation 244 256	abstain from
E5	Negation:T11 Negates:E6
T12	Procedure 267 292	dermatological procedures
E6	Procedure:T12 Name:T13
T13	Procedure-Name 267 292	dermatological procedures
T14	Procedure 296 306	treatments
E7	Procedure:T14 
T16	Procedure 333 350	wrinkle reduction
E9	Procedure:T16 Name:T17
T17	Procedure-Name 333 350	wrinkle reduction
R2	Example-Of Arg1:E9 Arg2:E7	
T18	Temporal-Connection 371 377	during
E10	Temporal-Connection:T18 Arg:E9 Arg2:E48
T21	Drug 447 460	anticoagulant
E11	Drug:T21 Name:T22 Temporality:E56
T22	Drug-Name 447 460	anticoagulant
T24	Eq-Comparison 529 543	within 2 weeks
E12	Eq-Comparison:T24 Operator:T27 Temporal-Unit:T25 Value:T26
T25	Eq-Temporal-Unit 538 543	weeks
A5	Eq-Temporal-Unit-Value T25 week
T26	Eq-Value 536 537	2
T27	Eq-Operator 529 535	within
A6	Eq-Operator-Value T27 LTEQ
T28	Temporal-Connection 544 546	of
E13	Temporal-Connection:T28 Arg:E12 Arg2:E47
T30	Drug 495 502	aspirin
E14	Drug:T30 Name:T31 Dose2:E8 Dose:E16
T31	Drug-Name 495 502	aspirin
T33	Eq-Comparison 504 526	100mg, up to 300mg/day
E16	Eq-Comparison:T33 Operator:T37 Value:T34 Unit:T35 Value2:T36 Unit2:T38 Per:T39
T34	Eq-Value 504 507	100
T35	Eq-Unit 507 509	mg
T36	Eq-Value 517 520	300
T37	Eq-Operator 511 516	up to
A8	Eq-Operator-Value T37 BETWEEN
T38	Eq-Unit 520 522	mg
T39	Eq-Temporal-Unit 523 526	day
A9	Eq-Temporal-Unit-Value T39 day
T40	Exception 471 480	exception
E17	Exception:T40 From:E11 Except:E14
T41	Drug 591 600	Vitamin E
E18	Drug:T41 Name:T42
T42	Drug-Name 591 600	Vitamin E
T43	Drug-Name 604 641	non-steroidal anti-inflammatory drugs
T46	Drug-Name 645 653	Collagen
T48	Eq-Comparison 654 667	within 1 week
E22	Eq-Comparison:T48 Operator:T49 Temporal-Unit:T51 Value:T50
T49	Eq-Operator 654 660	within
A10	Eq-Operator-Value T49 LTEQ
T50	Eq-Value 661 662	1
T51	Eq-Temporal-Unit 663 667	week
A11	Eq-Temporal-Unit-Value T51 week
T52	Temporal-Connection 668 670	of
E23	Temporal-Connection:T52 Arg:E22 Arg2:E44
T55	Condition 766 783	bleeding disorder
E24	Condition:T55 Name:T56 Temporality:E25 Temporality2:E49
T56	Condition-Name 766 783	bleeding disorder
T57	Eq-Comparison 787 791	past
E25	Eq-Comparison:T57 Temporal-Period:T58
T58	Eq-Temporal-Period 787 791	past
T60	Eq-Comparison 795 802	present
E27	Eq-Comparison:T60 Temporal-Period:T61
T61	Eq-Temporal-Period 795 802	present
T62	Procedure 817 829	deep-peeling
E28	Procedure:T62 Name:T63 Temporality:E54
T63	Procedure-Name 817 829	deep-peeling
T64	Procedure 831 848	skin regeneration
E29	Procedure:T64 Name:T65
T65	Procedure-Name 831 848	skin regeneration
T66	Procedure 850 865	plastic surgery
E30	Procedure:T66 Name:T67
T67	Procedure-Name 850 865	plastic surgery
T68	Procedure 877 902	botulinum toxin injection
E31	Procedure:T68 Name:T69
T69	Procedure-Name 877 902	botulinum toxin injection
R4	Example-Of Arg1:E31 Arg2:E30	
T70	Procedure 905 924	wrinkle improvement
E32	Procedure:T70 Name:T71
T71	Procedure-Name 905 924	wrinkle improvement
T72	Procedure 928 947	acne scar treatment
E33	Procedure:T72 Name:T73 Temporality:E36
T73	Procedure-Name 928 947	acne scar treatment
T76	Temporal-Connection 983 985	of
E35	Temporal-Connection:T76 Arg:E36 Arg2:E46
T78	Eq-Comparison 967 982	within 24 weeks
E36	Eq-Comparison:T78 Operator:T79 Temporal-Unit:T81 Value:T80
T79	Eq-Operator 967 973	within
A16	Eq-Operator-Value T79 LTEQ
T80	Eq-Value 974 976	24
T81	Eq-Temporal-Unit 977 982	weeks
A17	Eq-Temporal-Unit-Value T81 week
T82	Drug 1033 1055	hyaluronic acid filler
E37	Drug:T82 Name:T83 Temporality:E39 Temporality2:E55
T83	Drug-Name 1033 1055	hyaluronic acid filler
T85	Temporal-Connection 1072 1074	of
E38	Temporal-Connection:T85 Arg:E39 Arg2:E45
T87	Eq-Comparison 1056 1071	within 24 weeks
E39	Eq-Comparison:T87 Operator:T88 Temporal-Unit:T90 Value:T89
T88	Eq-Operator 1056 1062	within
A19	Eq-Operator-Value T88 LTEQ
T89	Eq-Value 1063 1065	24
T90	Eq-Temporal-Unit 1066 1071	weeks
A20	Eq-Temporal-Unit-Value T90 week
A3	Eq-Temporal-Period-Value T58 past
A13	Eq-Temporal-Period-Value T61 present
T15	Eq-Comparison 484 487	low
E8	Eq-Comparison:T15 Value:T32
T32	Eq-Value 484 487	low
T44	Or 925 927	or
E15	Or:T44 Arg:E32 Arg2:E33
T45	Or 642 644	or
E19	Or:T45 Arg:E21 Arg2:E26
T47	Or 601 603	or
E20	Or:T47 Arg:T42 Arg2:E21
T59	Drug 604 641	non-steroidal anti-inflammatory drugs
E21	Drug:T59 Name:T43
T74	Drug 645 653	Collagen
E26	Drug:T74 Name:T46 Temporality:E22
T92	Or 792 794	or
E34	Or:T92 Arg:E25 Arg2:E27
T93	Observation 70 103	appearance of the nasolabial fold
E40	Observation:T93 Name:T94
T94	Observation-Name 70 103	appearance of the nasolabial fold
T95	And 130 133	and
E41	And:T95 Arg:E40 Arg2:E3
T96	Or 293 295	or
E42	Or:T96 Arg:E6 Arg2:E7
T97	Assertion 231 243	consented to
E43	Assertion:T97 Asserted:E5
A21	Assertion-Type-Value E1 intention
A14	Assertion-Type-Value E43 hypothetical
A4	Temporal-Connection-Type-Value E10 during
A7	Temporal-Connection-Type-Value E13 before
A12	Temporal-Connection-Type-Value E23 before
A15	Temporal-Connection-Type-Value E38 before
A18	Temporal-Connection-Type-Value E35 before
T19	Study 687 696	screening
E44	Study:T19 
T29	Study 1091 1100	screening
E45	Study:T29 
T53	Study 1002 1011	screening
E46	Study:T53 
T23	Study 563 572	screening
E47	Study:T23 
T20	Study 399 404	study
E48	Study:T20 
T98	Eq-Comparison 755 762	History
E49	Eq-Comparison:T98 Temporal-Period:T99
T99	Eq-Temporal-Period 755 762	History
A22	Eq-Temporal-Period-Value T99 past
T54	Study 744 749	study
E50	Study:T54 
T75	Temporal-Connection 719 725	during
E51	Temporal-Connection:T75 Arg:E53 Arg2:E50
A23	Temporal-Connection-Type-Value E51 during
T77	Assertion 705 712	require
E52	Assertion:T77 Asserted:E53
A24	Assertion-Type-Value E52 hypothetical
T84	Coreference 713 718	these
E53	Coreference:T84 Refers-To:E26
T86	Eq-Comparison 808 816	Received
E54	Eq-Comparison:T86 Temporal-Period:T91
T91	Eq-Temporal-Period 808 816	Received
A25	Eq-Temporal-Period-Value T91 past
T100	Eq-Comparison 1017 1029	Administered
E55	Eq-Comparison:T100 Temporal-Period:T101
T101	Eq-Temporal-Period 1017 1029	Administered
A26	Eq-Temporal-Period-Value T101 past
T102	Eq-Comparison 431 443	Administered
E56	Eq-Comparison:T102 Temporal-Period:T103
T103	Eq-Temporal-Period 431 443	Administered
A27	Eq-Temporal-Period-Value T103 past
T104	Eq-Comparison 578 590	Administered
E57	Eq-Comparison:T104 Temporal-Period:T105
T105	Eq-Temporal-Period 578 590	Administered
A28	Eq-Temporal-Period-Value T105 past
